&Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.4M Buy
17,693
+2,274
+15% +$1.14M 0.04% 376
2025
Q4
$7.21M Buy
15,419
+620
+4% +$288K 0.04% 386
2025
Q3
$6.31M Buy
14,799
+96
+0.7% +$37.2K 0.04% 365
2025
Q2
$5.64M Buy
14,703
+858
+6% +$309K 0.04% 343
2025
Q1
$4.74M Buy
13,845
+138
+1% +$44.4K 0.05% 308
2024
Q4
$4.1M Buy
13,707
+3,204
+31% +$1.12M 0.05% 311
2024
Q3
$4.27M Sell
10,503
-259
-2% -$94.8K 0.08% 227
2024
Q2
$3.46M Buy
10,762
+168
+2% +$54.6K 0.15% 152
2024
Q1
$3.53M Buy
10,594
+2,735
+35% +$836K 0.49% 40
2023
Q4
$2.13M Buy
7,859
+33
+0.4% +$8.16K 0.52% 47
2023
Q3
$1.93M Buy
7,826
+2,929
+60% +$801K 0.9% 22
2023
Q2
$1.49M Buy
+4,897
New +$1.36M 0.67% 27
2022
Q2
Sell
-2,975
Closed -$746K 203
2022
Q1
$746K Sell
2,975
-250
-8% -$62.8K 0.42% 57
2021
Q4
$829K Sell
3,225
-22
-0.7% -$5.38K 0.5% 47
2021
Q3
$788K Hold
3,247
0.5% 49
2021
Q2
$671K Sell
3,247
-20
-0.6% -$4.08K 0.43% 59
2021
Q1
$615K Buy
3,267
+22
+0.7% +$3.88K 0.45% 60
2020
Q4
$534K Buy
3,245
+80
+3% +$11.7K 0.45% 58
2020
Q3
$395K Buy
3,165
+125
+4% +$15.5K 0.4% 67
2020
Q2
$295K Buy
+3,040
New +$316K 0.36% 73

Other funds holding HCA

&Partners's HCA Position: Q1 2026 in Review

&Partners increased its HCA Healthcare (HCA) stake by 15% in Q1 2026, buying an estimated $1.14M and bringing the position to 17,693 shares worth $8.4M. The position accounts for 0.04% of the portfolio, ranked #376.

&Partners first reported a position in HCA in Q2 2020 and has held it in 20 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • &Partners held 17,693 shares of HCA Healthcare worth $8.4M as of Q1 2026.
  • &Partners bought 2,274 HCA Healthcare shares in Q1 2026, an estimated $1.14M.
  • HCA Healthcare made up 0.04% of &Partners's portfolio in Q1 2026, its #376 holding.
  • &Partners first reported a position in HCA Healthcare in Q2 2020 and has held it in 20 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.